Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Millions | Total | Series A Preferred Stock | Series B Preferred Stock | Preferred Stock Issued and Outstanding | Common Stock Issued and Outstanding | Common Stock Issued and Outstanding Series A Preferred Stock | Common Stock Issued and Outstanding Series B Preferred Stock | Additional Paid-In Capital | (Accumulated Deficit) Retained Earnings | Accumulated Other Comprehensive Loss |
Preferred stock, beginning balance (in shares) at Dec. 31, 2022 | | | | 4,000,000 | | | | | | |
Beginning balance at Dec. 31, 2022 | $ 2,127 | | | $ 0 | $ 0 | | | $ 2,558 | $ (164) | $ (267) |
Common stock, beginning balance (in shares) at Dec. 31, 2022 | | | | | 233,403,912 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 26 | | | | | | | | 26 | |
Fair value change - derivatives | (9) | | | | | | | | | (9) |
Foreign currency translation adjustment | 14 | | | | | | | | | 14 |
Gain on dedesignated derivatives amortized from AOCI into income | (4) | | | | | | | | | (4) |
Preferred Stock dividend (in shares) | | | | | | | 1,082,877 | | | |
Share repurchases (in shares) | | | | | (541,316) | | | | | |
Share repurchases | (12) | | | | | | | (12) | | |
Profit sharing plan contributions (in shares) | | | | | 631,194 | | | | | |
Profit sharing plan contributions | 14 | | | | | | | 14 | | |
Share-based compensation and other, net (in shares) | | | | | 636,233 | | | | | |
Share-based compensation and other, net | 9 | | | | | | | 9 | | |
Preferred stock, ending balance (in shares) at Mar. 31, 2023 | | | | 4,000,000 | | | | | | |
Ending balance at Mar. 31, 2023 | 2,165 | | | $ 0 | $ 0 | | | 2,569 | (138) | (266) |
Common stock, ending balance (in shares) at Mar. 31, 2023 | | | | | 235,212,900 | | | | | |
Preferred stock, beginning balance (in shares) at Dec. 31, 2022 | | | | 4,000,000 | | | | | | |
Beginning balance at Dec. 31, 2022 | 2,127 | | | $ 0 | $ 0 | | | 2,558 | (164) | (267) |
Common stock, beginning balance (in shares) at Dec. 31, 2022 | | | | | 233,403,912 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 128 | | | | | | | | | |
Fair value change - derivatives | 7 | | | | | | | | | |
Foreign currency translation adjustment | (22) | | | | | | | | | |
Preferred Stock dividend (in shares) | | | 935,285 | | | | | | | |
Preferred stock, ending balance (in shares) at Sep. 30, 2023 | | | | 4,000,000 | | | | | | |
Ending balance at Sep. 30, 2023 | 2,232 | | | $ 0 | $ 0 | | | 2,562 | (36) | (294) |
Common stock, ending balance (in shares) at Sep. 30, 2023 | | | | | 235,146,035 | | | | | |
Preferred stock, beginning balance (in shares) at Mar. 31, 2023 | | | | 4,000,000 | | | | | | |
Beginning balance at Mar. 31, 2023 | 2,165 | | | $ 0 | $ 0 | | | 2,569 | (138) | (266) |
Common stock, beginning balance (in shares) at Mar. 31, 2023 | | | | | 235,212,900 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 48 | | | | | | | | 48 | |
Fair value change - derivatives | 15 | | | | | | | | | 15 |
Foreign currency translation adjustment | 27 | | | | | | | | | 27 |
Gain on dedesignated derivatives amortized from AOCI into income | (4) | | | | | | | | | (4) |
Preferred Stock dividend (in shares) | | | | | | | 436,992 | | | |
Share repurchases (in shares) | | | | | (428,688) | | | | | |
Share repurchases | (11) | | | | | | | (11) | | |
Share-based compensation and other, net (in shares) | | | | | 49,201 | | | | | |
Share-based compensation and other, net | 7 | | | | | | | 7 | | |
Preferred stock, ending balance (in shares) at Jun. 30, 2023 | | | | 4,000,000 | | | | | | |
Ending balance at Jun. 30, 2023 | 2,247 | | | $ 0 | $ 0 | | | 2,565 | (90) | (228) |
Common stock, ending balance (in shares) at Jun. 30, 2023 | | | | | 235,270,405 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 54 | | | | | | | | 54 | |
Fair value change - derivatives | 1 | | | | | | | | | 1 |
Foreign currency translation adjustment | (63) | | | | | | | | | (63) |
Gain on dedesignated derivatives amortized from AOCI into income | (4) | | | | | | | | | (4) |
Preferred Stock dividend (in shares) | | | 413,135 | | | | | | | |
Share repurchases (in shares) | | | | | (656,489) | | | | | |
Share repurchases | (18) | | | | | | | (18) | | |
Share-based compensation and other, net (in shares) | | | | | 532,119 | | | | | |
Share-based compensation and other, net | 15 | | | | | | | 15 | | |
Preferred stock, ending balance (in shares) at Sep. 30, 2023 | | | | 4,000,000 | | | | | | |
Ending balance at Sep. 30, 2023 | 2,232 | | | $ 0 | $ 0 | | | 2,562 | (36) | (294) |
Common stock, ending balance (in shares) at Sep. 30, 2023 | | | | | 235,146,035 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Preferred Stock dividend (in shares) | | | 337,044 | | | | | | | |
Preferred stock, ending balance (in shares) at Dec. 31, 2023 | | 4,000,000 | 800,000 | 4,000,000 | | | | | | |
Ending balance at Dec. 31, 2023 | 2,071 | | | $ 0 | $ 0 | | | 2,572 | (11) | (490) |
Common stock, ending balance (in shares) at Dec. 31, 2023 | | | | | 235,575,316 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 45 | | | | | | | | 45 | |
Fair value change - derivatives | 13 | | | | | | | | | 13 |
Foreign currency translation adjustment | (42) | | | | | | | | | (42) |
Gain on dedesignated derivatives amortized from AOCI into income | (4) | | | | | | | | | (4) |
Preferred Stock dividend (in shares) | | | | | | 7,944,104 | 620,240 | | | |
Series B Preferred Stock dividend | 0 | | | | | | | 7 | (7) | |
Conversion of Series B Preferred Stock, net (in shares) | | | | | 16,260,163 | | | | | |
Conversion of Series B Preferred Stock, net | 197 | | | | | | | 214 | (17) | |
Profit sharing plan contributions (in shares) | | | | | 510,319 | | | | | |
Profit sharing plan contributions | 18 | | | | | | | 18 | | |
Share-based compensation and other, net (in shares) | | | | | 726,809 | | | | | |
Share-based compensation and other, net | 3 | | | | | | | 3 | | |
Preferred stock, ending balance (in shares) at Mar. 31, 2024 | | | | 4,000,000 | | | | | | |
Ending balance at Mar. 31, 2024 | 2,301 | | | $ 0 | $ 0 | | | 2,814 | 10 | (523) |
Common stock, ending balance (in shares) at Mar. 31, 2024 | | | | | 261,636,951 | | | | | |
Preferred stock, beginning balance (in shares) at Dec. 31, 2023 | | 4,000,000 | 800,000 | 4,000,000 | | | | | | |
Beginning balance at Dec. 31, 2023 | 2,071 | | | $ 0 | $ 0 | | | 2,572 | (11) | (490) |
Common stock, beginning balance (in shares) at Dec. 31, 2023 | | | | | 235,575,316 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 183 | | | | | | | | | |
Fair value change - derivatives | (5) | | | | | | | | | |
Foreign currency translation adjustment | 26 | | | | | | | | | |
Preferred Stock dividend (in shares) | | | 283,196 | | | | | | | |
Preferred stock, ending balance (in shares) at Sep. 30, 2024 | | 4,000,000 | 0 | 4,000,000 | | | | | | |
Ending balance at Sep. 30, 2024 | 2,967 | | | $ 0 | $ 0 | | | 3,300 | 148 | (481) |
Common stock, ending balance (in shares) at Sep. 30, 2024 | | | | | 274,761,552 | | | | | |
Preferred stock, beginning balance (in shares) at Mar. 31, 2024 | | | | 4,000,000 | | | | | | |
Beginning balance at Mar. 31, 2024 | 2,301 | | | $ 0 | $ 0 | | | 2,814 | 10 | (523) |
Common stock, beginning balance (in shares) at Mar. 31, 2024 | | | | | 261,636,951 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 69 | | | | | | | | 69 | |
Fair value change - derivatives | 4 | | | | | | | | | 4 |
Foreign currency translation adjustment | (1) | | | | | | | | | (1) |
Gain on dedesignated derivatives amortized from AOCI into income | (4) | | | | | | | | | (4) |
Issuance of common shares (in shares) | | | | | 12,650,000 | | | | | |
Issuance of common shares | 458 | | | | | | | 458 | | |
Share-based compensation and other, net (in shares) | | | | | 32,702 | | | | | |
Share-based compensation and other, net | 8 | | | | | | | 8 | | |
Preferred stock, ending balance (in shares) at Jun. 30, 2024 | | | | 4,000,000 | | | | | | |
Ending balance at Jun. 30, 2024 | 2,835 | | | $ 0 | $ 0 | | | 3,280 | 79 | (524) |
Common stock, ending balance (in shares) at Jun. 30, 2024 | | | | | 274,319,653 | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | |
Net income | 69 | | | | | | | | 69 | |
Fair value change - derivatives | (22) | | | | | | | | | (22) |
Foreign currency translation adjustment | 69 | | | | | | | | | 69 |
Gain on dedesignated derivatives amortized from AOCI into income | (4) | | | | | | | | | (4) |
Share-based compensation and other, net (in shares) | | | | | 441,899 | | | | | |
Share-based compensation and other, net | 20 | | | | | | | 20 | | |
Preferred stock, ending balance (in shares) at Sep. 30, 2024 | | 4,000,000 | 0 | 4,000,000 | | | | | | |
Ending balance at Sep. 30, 2024 | $ 2,967 | | | $ 0 | $ 0 | | | $ 3,300 | $ 148 | $ (481) |
Common stock, ending balance (in shares) at Sep. 30, 2024 | | | | | 274,761,552 | | | | | |